Aminoglutethimide-induced lysosomal changes in adrenal gland in mice

Exp Toxicol Pathol. 2017 Sep 5;69(7):424-429. doi: 10.1016/j.etp.2017.04.004. Epub 2017 Apr 11.

Abstract

Aminoglutethimide is a steroidogenesis inhibitor and inhibits a cholesterol side-chain cleavage enzyme (CYP11A1) that converts cholesterol to pregnenolone in mitochondria. We investigated histopathological changes induced by 5-day administration of AG in mice. Cytoplasmic vacuoles of various sizes and single cell necrosis were found in zona fasciculata cells in AG-treated mice. Some vacuoles were positive for adipophilin, whereas others were positive for lysosome-associated membrane protein-2 on immunohistochemical staining, indicating they were enlarged lipid droplets and lysosomes, respectively. Electron microscopy revealed enlarged lysosomes containing damaged mitochondria and lamellar bodies in zona fasciculata cells, and they were considered to reflect the intracellular protein degradation processes, mitophagy and lipophagy. From these results, we showed that AG induces excessive lipid accumulation and mitochondrial damage in zona fasciculata cells, which leads to an accelerated lysosomal degradation in mice.

Keywords: Adrenal toxicity; Aminoglutethimide; Autophagy; Mouse.

MeSH terms

  • Adrenal Glands / drug effects*
  • Adrenal Glands / pathology*
  • Aminoglutethimide / toxicity*
  • Animals
  • Aromatase Inhibitors / toxicity*
  • Lysosomes / drug effects*
  • Lysosomes / pathology
  • Male
  • Mice

Substances

  • Aromatase Inhibitors
  • Aminoglutethimide